Telomere dysfunction and tumour suppression: the senescence connection
- 1 June 2008
- journal article
- review article
- Published by Springer Nature in Nature Reviews Cancer
- Vol. 8 (6) , 450-458
- https://doi.org/10.1038/nrc2393
Abstract
Telomeres are TTAGGG repetitive sequences that cap the ends of eukaryotic chromosomes. A core of telomere binding proteins, termed the shelterin complex, serve to protect telomeric ends. Critical telomere shortening or uncapping of telomere binding proteins results in telomere dysfunction. Dysfunctional telomeres activate a DNA damage response. In the setting of a competent p53 pathway, this initiates senescence and apoptotic programmes to inhibit tumorigenesis. In cells with mutant p53, dysfunctional telomeres promote genome instability and progression to cancer. Cellular senescence is as potent as apoptosis in suppressing spontaneous tumorigenesis in mouse models of telomere dysfunction.Keywords
This publication has 101 references indexed in Scilit:
- Targeting telomerase for cancer therapeuticsBritish Journal of Cancer, 2008
- Pot1 and cell cycle progression cooperate in telomere length regulationNature Structural & Molecular Biology, 2007
- Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancersNature, 2007
- Short Telomeres Limit Tumor Progression In Vivo by Inducing SenescencePublished by Elsevier ,2007
- Telomere dysfunction suppresses spontaneous tumorigenesis in vivo by initiating p53‐dependent cellular senescenceEMBO Reports, 2007
- Restoration of p53 function leads to tumour regression in vivoNature, 2007
- Activation of the DNA damage checkpoint and genomic instability in human precancerous lesionsNature, 2005
- DNA damage response as a candidate anti-cancer barrier in early human tumorigenesisNature, 2005
- A DNA damage checkpoint response in telomere-initiated senescenceNature, 2003
- Telomeres shorten during ageing of human fibroblastsNature, 1990